SSA
ARCK

Schonfeld Strategic Advisors’s Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock ARCK Stock Holding History

Schonfeld Strategic Advisors’s Portfolio ARCK Stock Details ARCK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,886
Closed -$109K – 3327
2022
Q2 		$109K Hold
10,886
– – ﹤0.01% 2111
2022
Q1 		$109K Buy
+10,886
New +$109K ﹤0.01% 2208

Other funds holding ARCK

SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return

Schonfeld Strategic Advisors's ARCK Position: Q3 2022 in Review

Schonfeld Strategic Advisors sold out of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) in Q3 2022, closing a stake of 10,886 shares — an estimated $109K sold.

Schonfeld Strategic Advisors first reported a position in ARCK in Q1 2022 and held it in 2 quarters. The position peaked at $109K in Q2 2022. 62 funds tracked by Wall St. Rank hold ARCK as of Q3 2022.

  • Schonfeld Strategic Advisors reported no remaining Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position as of Q3 2022 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 10,886 Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock shares in Q3 2022, an estimated $109K.
  • Schonfeld Strategic Advisors first reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in Q1 2022 and held it in 2 quarters.
  • Schonfeld Strategic Advisors's Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position peaked at $109K in Q2 2022.
  • 62 funds tracked by Wall St. Rank held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock as of Q3 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.